PLAC8 Contributes to the Malignant Behaviors of Cervical Cancer Cells by Activating the SOX4-mediated AKT Pathway

Overview

Journal Histochem Cell Biol

Publisher Springer

Specialties Biochemistry
Cell Biology

Date 2023 Jan 5

PMID 36602585

Authors

Boya Deng

Siyang Zhang

Yingying Zhou

Ying Zhu

Jing Fei

Ailin Li

Affiliations

Soon will be listed here.

Abstract

Cervical cancer (CC) is the primary cancer-related cause of morbidity and mortality in women. Previous studies have shown that placenta-specific 8 (PLAC8) has different functions in multiple malignancies. This study aimed to explore the function and regulatory mechanism of PLAC8 in CC. Bioinformatics and immunohistochemical analyses demonstrated that PLAC8 was significantly upregulated in CC tissues compared with normal tissues. Gain/loss-of-function experiments showed that siRNA-mediated knockdown of PLAC8 suppressed cell migration and invasion, while PLAC8 overexpression promoted cell motility. Moreover, PLAC8 was revealed to affect the epithelial-mesenchymal transition (EMT) process by upregulating epithelial (E)-cadherin and decreasing the expression of mesenchymal markers of EMT, including vimentin, zinc finger E-box binding homeobox 1 (ZEB1), neural (N)-cadherin, matrix metalloproteinase-9 (MMP-9), and MMP-2 in PLAC8-silenced cells. PLAC8 activated the AKT pathway, as proven by the downregulation of p-AKT and p-AKT expression after PLAC8 knockdown. Furthermore, PLAC8 overexpression upregulated the expression of sex-determining region Y-related high-mobility group box transcription factor 4 (SOX4), which is reported to mediate the activation of the AKT pathway, and SOX4 deficiency reversed the cellular functions caused by PLAC8 overexpression. Overall, the present study indicates that PLAC8 may facilitate CC development by activating the SOX4-mediated AKT pathway, suggesting that PLAC8 may serve as a potential biomarker for CC treatment.

References

Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H . New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother. 2021; 141:111824. DOI: 10.1016/j.biopha.2021.111824. View

Bardin A, Vaccarella S, Clifford G, Lissowska J, Rekosz M, Bobkiewicz P . Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer. 2008; 44(4):557-64. DOI: 10.1016/j.ejca.2007.12.001. View

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal J . The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008; 8(3):187-98. DOI: 10.2174/156800908784293659. View

Popov I, Ray H, Skoglund P, Keller R, Chang C . The RhoGEF protein Plekhg5 regulates apical constriction of bottle cells during gastrulation. Development. 2018; 145(24). PMC: 6307888. DOI: 10.1242/dev.168922. View

Ediriweera M, Tennekoon K, Samarakoon S . Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance. Semin Cancer Biol. 2019; 59:147-160. DOI: 10.1016/j.semcancer.2019.05.012. View

Galaviz-Hernandez C, Stagg C, de Ridder G, Tanaka T, Ko M, Schlessinger D . Plac8 and Plac9, novel placental-enriched genes identified through microarray analysis. Gene. 2003; 309(2):81-9. DOI: 10.1016/s0378-1119(03)00508-0. View

Harro C, Pang Y, Roden R, Hildesheim A, Wang Z, Reynolds M . Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst. 2001; 93(4):284-92. DOI: 10.1093/jnci/93.4.284. View

Huang M, Zou Y, Yang R, Jiang Y, Sheng J, Han J . Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway. Exp Cell Res. 2018; 374(1):172-180. DOI: 10.1016/j.yexcr.2018.11.021. View

Huang M, Qi C, Zou Y, Yang R, Jiang Y, Sheng J . Plac8-mediated autophagy regulates nasopharyngeal carcinoma cell function via AKT/mTOR pathway. J Cell Mol Med. 2020; 24(14):7778-7788. PMC: 7348153. DOI: 10.1111/jcmm.15409. View

10.

Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie S . The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 2018; 9(6):603. PMC: 5964121. DOI: 10.1038/s41419-018-0580-3. View

11.

Kaistha B, Lorenz H, Schmidt H, Sipos B, Pawlak M, Gierke B . PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways. Cancer Res. 2015; 76(1):96-107. DOI: 10.1158/0008-5472.CAN-15-0216. View

12.

Kolluru V, Pal D, John A, Ankem M, Freedman J, Damodaran C . Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis. Cancer Lett. 2017; 408:121-129. PMC: 7521630. DOI: 10.1016/j.canlet.2017.08.023. View

13.

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

14.

Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell A . Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest. 2014; 124(5):2172-87. PMC: 4001536. DOI: 10.1172/JCI71103. View

15.

Mao M, Chen Y, Jia Y, Yang J, Wei Q, Li Z . PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway. J Cell Mol Med. 2019; 23(10):6930-6941. PMC: 6787500. DOI: 10.1111/jcmm.14578. View

16.

Mehta G, Parker J, Silva G, Hoadley K, Perou C, Gatza M . Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Res Treat. 2017; 162(3):439-450. PMC: 5334195. DOI: 10.1007/s10549-017-4139-2. View

17.

Morel A, Hinkal G, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A . EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 2012; 8(5):e1002723. PMC: 3359981. DOI: 10.1371/journal.pgen.1002723. View

18.

Paskeh M, Mirzaei S, Gholami M, Zarrabi A, Zabolian A, Hashemi M . Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies. Biomed Pharmacother. 2021; 144:112335. DOI: 10.1016/j.biopha.2021.112335. View

19.

Qureshi R, Arora H, Rizvi M . EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett. 2014; 356(2 Pt B):321-31. DOI: 10.1016/j.canlet.2014.09.021. View

20.

Ruan H, Yang H, Wei H, Xiao W, Lou N, Qiu B . Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition. Int J Oncol. 2017; 51(1):336-346. DOI: 10.3892/ijo.2017.4010. View